136 related articles for article (PubMed ID: 311341)
41. Further studies of macrophages in relationship to avirulent Semliki Forest virus infections.
Oaten SW; Jagelman S; Webb HE
Br J Exp Pathol; 1980 Apr; 61(2):150-5. PubMed ID: 6775662
[TBL] [Abstract][Full Text] [Related]
42. Identification of a DTH-inducing T-cell epitope on the E2 membrane protein of Semliki Forest virus.
Snijders A; Benaissa-Trouw BJ; Oosting JD; Snippe H; Kraaijeveld CA
Cell Immunol; 1989 Oct; 123(1):23-35. PubMed ID: 2476243
[TBL] [Abstract][Full Text] [Related]
43. Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of myocrisin and 1-asparaginase.
Bradish CJ; Allner K; Fitzgeorge R
J Gen Virol; 1975 Aug; 28(2):239-50. PubMed ID: 809543
[TBL] [Abstract][Full Text] [Related]
44. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
Balcarova J; Helenius A; Simons K
J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
[TBL] [Abstract][Full Text] [Related]
45. Blocking by anti-idiotypic antibodies of monoclonal antibody-mediated protection against lethal Semliki Forest virus in mice.
Oosterlaken TA; Harmsen M; Kraaijeveld CA; Snippe H
Scand J Immunol; 1990 Feb; 31(2):159-65. PubMed ID: 2155475
[TBL] [Abstract][Full Text] [Related]
46. The pathogenesis of avirulent Semliki Forest virus infections in athymic nude mice.
Jagelman S; Suckling AJ; Webb HE; Bowen FT
J Gen Virol; 1978 Dec; 41(3):599-607. PubMed ID: 745010
[TBL] [Abstract][Full Text] [Related]
47. Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.
Nilsson C; Mäkitalo B; Berglund P; Bex F; Liljeström P; Sutter G; Erfle V; ten Haaft P; Heeney J; Biberfeld G; Thorstensson R
Vaccine; 2001 May; 19(25-26):3526-36. PubMed ID: 11348720
[TBL] [Abstract][Full Text] [Related]
48. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
Cabrera A; Sáez D; Céspedes S; Andrews E; Oñate A
Immunobiology; 2009; 214(6):467-74. PubMed ID: 19150742
[TBL] [Abstract][Full Text] [Related]
49. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge.
Grosfeld H; Velan B; Leitner M; Cohen S; Lustig S; Lachmi BE; Shafferman A
J Virol; 1989 Aug; 63(8):3416-22. PubMed ID: 2473217
[TBL] [Abstract][Full Text] [Related]
50. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
Boere WA; Kraaijeveld CA; Snippe H
Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
[No Abstract] [Full Text] [Related]
51. Delayed-type hypersensitivity in mice after infection with avirulent Semliki Forest virus. Brief report.
Kraaijeveld CA; Jansen J; Benaissa-Trouw B; Snippe H
Arch Virol; 1983; 78(1-2):115-8. PubMed ID: 6316872
[TBL] [Abstract][Full Text] [Related]
52. Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus.
Johnston LJ; Halliday GM; King NJ
J Invest Dermatol; 2000 Mar; 114(3):560-8. PubMed ID: 10692118
[TBL] [Abstract][Full Text] [Related]
53. Increased influenza pneumonia mortality of mice adoptively immunized with node and spleen cells sensitized by inactivated but not live virus.
Cate TR; Mold NG
Infect Immun; 1975 May; 11(5):908-14. PubMed ID: 47313
[TBL] [Abstract][Full Text] [Related]
54. Pathogenesis of in utero infections with abortogenic and non-abortogenic alphaviruses in mice.
Milner AR; Marshall ID
J Virol; 1984 Apr; 50(1):66-72. PubMed ID: 6321801
[TBL] [Abstract][Full Text] [Related]
55. Cross-protection correlates with delayed antibody formation to challenge virus after immunization with Sindbis virus.
Smith-Owirodu A; Wust CJ; Gates D; Brown A
J Gen Virol; 1980 Dec; 51(Pt 2):351-7. PubMed ID: 7229617
[TBL] [Abstract][Full Text] [Related]
56. Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. I. Passive transfer of protection with immune serum and immune cells.
Rabinowitz SG; Adler WH
J Immunol; 1973 May; 110(5):1345-53. PubMed ID: 4348975
[No Abstract] [Full Text] [Related]
57. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
Dimmock NJ; Kennedy SI
J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
[TBL] [Abstract][Full Text] [Related]
58. Efficient induction of Semliki Forest virus and mumps virus neutralizing anti-anti-idiotypic antibodies using Quil A as adjuvant.
Oosterlaken TA; Brandenburg A; Schielen P; Fransen R; Kraaijeveld CA; Snippe H
J Immunol Methods; 1991 Feb; 136(2):169-75. PubMed ID: 1999649
[TBL] [Abstract][Full Text] [Related]
59. Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition.
de Mare A; Lambeck AJ; Regts J; van Dam GM; Nijman HW; Snippe H; Wilschut J; Daemen T
Gene Ther; 2008 Mar; 15(6):393-403. PubMed ID: 18004406
[TBL] [Abstract][Full Text] [Related]
60. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.
Snijders A; Benaissa-Trouw BJ; Oosterlaken TA; Puijk WC; Posthumus WP; Meloen RH; Boere WA; Oosting JD; Kraaijeveld CA; Snippe H
J Gen Virol; 1991 Mar; 72 ( Pt 3)():557-65. PubMed ID: 1706409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
